arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Strata Critical Medical, Inc.

SRTA
$5.80 ▲ +0.21 (+3.76%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
26 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
49
Health
Weak
Bullish
auto_awesome

Analytical Summary

Strata Critical Medical, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $494.9M
Dividend Yield
Revenue Growth 24.1%
Op. Margin -4.4%
ROIC -1.0%
FCF / Share $-0.02
Trailing P/E 193.3x
Price / Book 1.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$67.38M
↑ +24.1%
Net Income Profit after all expenses
$2.15M
↑ +124.4%
Operating Margin Operating profit as % of sales
-4.4%
↑ +54.0% 14th
FCF / Share Free cash flow per share
$-0.02
↑ +57.7%
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability
35
Returns
80
Cash Quality
8

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters